{"Symbol": "VRTX", "AssetType": "Common Stock", "Name": "Vertex Pharmaceuticals Incorporated", "Description": "Vertex Pharmaceuticals, Inc. is an American biopharmaceutical company based in Boston, Massachusetts.", "CIK": "875320", "Exchange": "NASDAQ", "Currency": "USD", "Country": "USA", "Sector": "LIFE SCIENCES", "Industry": "PHARMACEUTICAL PREPARATIONS", "Address": "50 NORTHERN AVENUE, BOSTON, MA, US", "FiscalYearEnd": "December", "LatestQuarter": "2021-09-30", "MarketCapitalization": "46146736000", "EBITDA": "2770692000", "PERatio": "21.77", "PEGRatio": "0.288", "BookValue": "37.2", "DividendPerShare": "None", "DividendYield": "0", "EPS": "8.34", "RevenuePerShareTTM": "27.56", "ProfitMargin": "0.305", "OperatingMarginTTM": "0.372", "ReturnOnAssetsTTM": "0.139", "ReturnOnEquityTTM": "0.246", "RevenueTTM": "7129659000", "GrossProfitTTM": "3639846000", "DilutedEPSTTM": "8.34", "QuarterlyEarningsGrowthYOY": "0.296", "QuarterlyRevenueGrowthYOY": "0.29", "AnalystTargetPrice": "253.91", "TrailingPE": "21.77", "ForwardPE": "14.27", "PriceToSalesRatioTTM": "6.47", "PriceToBookRatio": "5.02", "EVToRevenue": "5.86", "EVToEBITDA": "14.25", "Beta": "0.604", "52WeekHigh": "242.99", "52WeekLow": "176.36", "50DayMovingAverage": "184.68", "200DayMovingAverage": "201.07", "SharesOutstanding": "254252000", "DividendDate": "None", "ExDividendDate": "None"}